Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of ocular surface health with DuoTrav APS versus Xalacom eye drops
2009-010604-29Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of travoprost + timolol in open-angle glaucoma (OAG), ocular hypertension and dry eye syndrome (DED) (2 arms), sponsored by Alcon Inc. Primary endpoint: Change in Ocular Surface Disease Index (OSDI) score at Day 90. Started Apr 2009; status: completed.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertensiondry eye syndrome (DED)
Beyond the preview
Go deeper on 2009-010604-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010604-29.